Literature DB >> 564739

Lassa, Marburg and Ebola: newly described African fevers.

S K Seah.   

Abstract

Entities:  

Mesh：

Year:  1978        PMID： 564739      PMCID： PMC1817968     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  Handling patients with suspected Lassa fever entering Great Britain.

Authors:  A W Woodruff
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

2.  A case of Ebola virus infection.

Authors:  R T Emond; B Evans; E T Bowen; G Lloyd
Journal:  Br Med J       Date:  1977-08-27

3.  The Lassa fever episode, Metro Toronto, August, 1976.

Authors:  E W Best
Journal:  Can J Public Health       Date:  1976 Sep-Oct

4.  Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. I. Epidemiologic studies.

Authors:  D W Fraser; C C Campbell; T P Monath; P A Goff; M B Gregg
Journal:  Am J Trop Med Hyg       Date:  1974-11       Impact factor: 2.345

5.  Lassa fever. A study of 23 hospital cases.

Authors:  H A White
Journal:  Trans R Soc Trop Med Hyg       Date:  1972       Impact factor: 2.184

6.  Marburg agent disease: in man.

Authors:  G A Martini
Journal:  Trans R Soc Trop Med Hyg       Date:  1969       Impact factor: 2.184

7.  Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire.

Authors:  K M Johnson; J V Lange; P A Webb; F A Murphy
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

8.  Recent isolations of Lassa virus from Nigerian rodents.

Authors:  H Wulff; A Fabiyi; T P Monath
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

Review 9.  Lassa fever: review of epidemiology and epizootiology.

Authors:  T P Monath
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

10.  Arenaviruses.

Authors:  J Casals
Journal:  Yale J Biol Med       Date:  1975-05
View more
  3 in total

1.  Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay.

Authors:  Hatem A Elshabrawy; Jilao Fan; Christine S Haddad; Kiira Ratia; Christopher C Broder; Michael Caffrey; Bellur S Prabhakar
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

Review 2.  Ebola virus outbreak, updates on current therapeutic strategies.

Authors:  Hatem A Elshabrawy; Timothy B Erickson; Bellur S Prabhakar
Journal:  Rev Med Virol       Date:  2015-05-11       Impact factor: 6.989

3.  Global Medicine, Parasites, and Tasmania.

Authors:  John Goldsmid; Silvana Bettiol
Journal:  Trop Med Infect Dis       Date:  2020-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.